Beacon Capital Management LLC (Tennessee)’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,000	Closed	-$7.55K	–	1030
2023 Q1	$7.55K	Hold	5,000	–	–	﹤0.01%	556
2022 Q4	$8K	Hold	5,000	–	–	﹤0.01%	551
2022 Q3	$9K	Buy	+5,000	New	+$9K	﹤0.01%	489